Skip to Main Content

Paper Details

Impact of Prediagnosis Risk of Major Depressive Disorder and Health-Related Quality of Life on Treatment Choice for Stage II-III Rectal Cancer.
JCO Clin Cancer Inform
0
2023
MDD, Major Depressive Disorder, Patients, Stage II-III Rectal Cancer, cancer, depressive disorders, depressive symptoms, major depressive disorder, patient, patients, stage II-III rectal adenocarcinoma, stage II-III rectal cancer
Author NameAffiliation
Tristan GroganDavid Geffen School of Medicine at university of california los angeles
Tristan GroganDavid Geffen School of Medicine at university of california los angeles
  • 1 - 2

Datasets

Release 1.2